Bone turnover markers in peripheral blood and marrow plasma reflect trabecular bone loss but not endocortical expansion in aging mice

Bone

Volumn 50, Issue 3, 2012, Pages 628-637

  Shahnazari, Mohammad ^a   Dwyer, Denise ^b   Chu, Vivian ^a   Asuncion, Frank ^b   Stolina, Marina ^b   Ominsky, Michael ^b   Kostenuik, Paul ^b   Halloran, Bernard ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AMGEN INC   (United States)

Author keywords

Aging; Biomarkers; Bone; Bone turnover; Marrow plasma

Indexed keywords

CATHEPSIN K; DICKKOPF 1 PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; SCLEROSTIN; TRANSCRIPTION FACTOR OSTERIX;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE TURNOVER; CELL CYCLE REGULATION; CELL FUNCTION; CONTROLLED STUDY; CROSS REACTION; DIAPHYSIS; ENZYME IMMUNOASSAY; EPIPHYSIS; LIMIT OF DETECTION; MALE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TRABECULAR BONE;

AGING; ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; BONE MARROW; BONE REMODELING; CELLS, CULTURED; MALE; MICE; OSTEOBLASTS; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND;

EID: 84856962930     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.11.010     Document Type: Article

References (34)

1. Melton L.J., Ilstrup D.M., Beckenbaugh R.D., Riggs B.L. Hip fracture recurrence. A population-based study. Clin Orthop Relat Res 1982, 131-138.
2. Weinstein R.S., Hutson M.S. Decreased trabecular width and increased trabecular spacing contribute to bone loss with aging. Bone 1987, 8:137-142.
3. Ensrud K.E., Palermo L., Black D.M., Cauley J., Jergas M., Orwoll E.S., et al. Hip and calcaneal bone loss increase with advancing age: longitudinal results from the study of osteoporotic fractures. J Bone Miner Res 1995, 10:1778-1787.
4. Cooper C., Melton L.J. Epidemiology of osteoporosis. Trends Endocrinol Metab 1992, 3:224-229.
5. O'Neill T.W., Felsenberg D., Varlow J., Cooper C., Kanis J.A., Silman A.J. The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 1996, 11:1010-1018.
6. Greendale G.A., Edelstein S., Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study. J Bone Miner Res 1997, 12:1833-1843.
7. Indridason O.S., Franzson L., Sigurdsson G. Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover. Osteoporos Int 2005, 16:417-423.
8. Amin S., Riggs B.L., Melton L.J., Achenbach S.J., Atkinson E.J., Khosla S. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women. J Bone Miner Res 2007, 22:799-807.
9. Kuchuk N.O., Pluijm S.M., van Schoor N.M., Looman C.W., Smit J.H., Lips P. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab 2009, 94:1244-1250.
10. Delmas P.D., Stenner D., Wahner H.W., Mann K.G., Riggs B.L. Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss. J Clin Invest 1983, 71:1316-1321.
11. Delmas P.D. Biochemical markers of bone turnover. J Bone Miner Res 1993, 8(Suppl 2):S549-S555.
12. Bauer D.C., Sklarin P.M., Stone K.L., Black D.M., Nevitt M.C., Ensrud K.E., et al. Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures. J Bone Miner Res 1999, 14:1404-1410.
13. Szulc P., Garnero P., Munoz F., Marchand F., Delmas P.D. Cross-sectional evaluation of bone metabolism in men. J Bone Miner Res 2001, 16:1642-1650.
14. Minisola S., Dionisi S., Pacitti M.T., Paglia F., Carnevale V., Scillitani A., et al. Gender differences in serum markers of bone resorption in healthy subjects and patients with disorders affecting bone. Osteoporos Int 2002, 13:171-175.
15. Delmas P.D. Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease. Endocrinol Metab Clin North Am 1990, 19:1-18.
16. Parfitt A.M., Mathews C.H., Villanueva A.R., Kleerekoper M., Frame B., Rao D.S. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest 1983, 72:1396-1409.
17. Pietschmann P., Skalicky M., Kneissel M., Rauner M., Hofbauer G., Stupphann D., et al. Bone structure and metabolism in a rodent model of male senile osteoporosis. Exp Gerontol 2007, 42:1099-1108.
18. Cao J.J., Wronski T.J., Iwaniec U., Phleger L., Kurimoto P., Boudignon B., et al. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. J Bone Miner Res 2005, 20:1659-1668.
19. Zebaze R.M., Ghasem-Zadeh A., Bohte A., Iuliano-Burns S., Mirams M., Price R.I., et al. Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study. Lancet 2010, 375:1729-1736.
20. Kostenuik P.J., Smith S.Y., Jolette J., Schroeder J., Pyrah I., Ominsky M.S. Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody. Bone 2011, 49:151-161.
21. Ferguson V.L., Ayers R.A., Bateman T.A., Simske S.J. Bone development and age-related bone loss in male C57BL/6J mice. Bone 2003, 33:387-398.
22. Rodda S.J., McMahon A.P. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 2006, 133:3231-3244.
23. Shim S.S. Physiology of blood circulation of bone. J Bone Joint Surg Am 1968, 50:812-824.
24. Yadav V.K., Ryu J.H., Suda N., Tanaka K.F., Gingrich J.A., Schutz G., et al. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 2008, 135:825-837.
25. Li X., Ominsky M.S., Niu Q.T., Sun N., Daugherty B., D'Agostin D., et al. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res 2008, 23:860-869.
26. Li J., Sarosi I., Cattley R.C., Pretorius J., Asuncion F., Grisanti M., et al. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia. Bone 2006, 39:754-766.
27. Tu X., Joeng K.S., Nakayama K.I., Nakayama K., Rajagopal J., Carroll T.J., et al. Noncanonical Wnt signaling through G protein-linked PKCdelta activation promotes bone formation. Dev Cell 2007, 12:113-127.
28. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Luthy R., et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997, 89:309-319.
29. Olesen P., Ledet T., Rasmussen L.M. Arterial osteoprotegerin: increased amounts in diabetes and modifiable synthesis from vascular smooth muscle cells by insulin and TNF-alpha. Diabetologia 2005, 48:561-568.
30. Yamaguchi K., Kinosaki M., Goto M., Kobayashi F., Tsuda E., Morinaga T., et al. Characterization of structural domains of human osteoclastogenesis inhibitory factor. J Biol Chem 1998, 273:5117-5123.
31. Drake M.T., Srinivasan B., Modder U.I., Peterson J.M., McCready L.K., Riggs B.L., et al. Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women. J Clin Endocrinol Metab 2010, 95:5056-5062.
32. Ominsky M.S., Stolina M., Li X., Corbin T.J., Asuncion F.J., Barrero M., et al. One year of transgenic overexpression of osteoprotegerin in rats suppressed bone resorption and increased vertebral bone volume, density, and strength. J Bone Miner Res 2009, 24:1234-1246.
33. Koch S., Nava P., Addis C., Kim W., Denning T.L., Li L., et al. The Wnt antagonist Dkk1 regulates intestinal epithelial homeostasis and wound repair. Gastroenterology 2011 Jul, 141(1):259-268.
34. Pfaff E.M., Becker S., Gunther A., Konigshoff M. Dickkopf proteins influence lung epithelial cell proliferation in idiopathic pulmonary fibrosis. Eur Respir J 2011, 37:79-87.